OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The landscape of objective response rate of anti-PD-1/L1 monotherapy across 31 types of cancer: a system review and novel biomarker investigating
Yize Mao, Hui Xie, Min‐Yi Lv, et al.
Cancer Immunology Immunotherapy (2023) Vol. 72, Iss. 7, pp. 2483-2498
Closed Access | Times Cited: 13
Yize Mao, Hui Xie, Min‐Yi Lv, et al.
Cancer Immunology Immunotherapy (2023) Vol. 72, Iss. 7, pp. 2483-2498
Closed Access | Times Cited: 13
Showing 13 citing articles:
Immunogenicity of cell death and cancer immunotherapy with immune checkpoint inhibitors
Elena Catanzaro, Manuel Beltrán‐Visiedo, Lorenzo Galluzzi, et al.
Cellular and Molecular Immunology (2024)
Open Access | Times Cited: 11
Elena Catanzaro, Manuel Beltrán‐Visiedo, Lorenzo Galluzzi, et al.
Cellular and Molecular Immunology (2024)
Open Access | Times Cited: 11
Neoadjuvant immunotherapy for dMMR and pMMR colorectal cancers: therapeutic strategies and putative biomarkers of response
Christopher J.M. Williams, Allyson Peddle, Pashtoon Murtaza Kasi, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 12, pp. 839-851
Closed Access | Times Cited: 9
Christopher J.M. Williams, Allyson Peddle, Pashtoon Murtaza Kasi, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 12, pp. 839-851
Closed Access | Times Cited: 9
Towards the Prediction of Responses to Cancer Immunotherapy: A Multi-Omics Review
Weichu Tao, Qian Sun, Bingxiang Xu, et al.
Life (2025) Vol. 15, Iss. 2, pp. 283-283
Open Access | Times Cited: 1
Weichu Tao, Qian Sun, Bingxiang Xu, et al.
Life (2025) Vol. 15, Iss. 2, pp. 283-283
Open Access | Times Cited: 1
Predicting immunotherapy prognosis and targeted therapy sensitivity of colon cancer based on a CAF-related molecular signature
Leqian Ying, Lu Zhang, Yanping Chen, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Leqian Ying, Lu Zhang, Yanping Chen, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Beyond the Point: Learning From Outcomes After Inpatient Immune Checkpoint Inhibitor Therapy
Ali Raza Khaki, Kerry L. Reynolds, Laura A. Petrillo
JCO Oncology Practice (2025)
Closed Access
Ali Raza Khaki, Kerry L. Reynolds, Laura A. Petrillo
JCO Oncology Practice (2025)
Closed Access
Integrated singlecell and bulk RNA-seq analysis identifies a prognostic signature related to inflammation in colorectal cancer
Wen Yin, Yin-Yong AO, Qian Jia, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Wen Yin, Yin-Yong AO, Qian Jia, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Programmed death-ligand 1 regulates ameloblastoma growth and recurrence
Linzhou Zhang, Hao Lin, Jiajie Liang, et al.
International Journal of Oral Science (2025) Vol. 17, Iss. 1
Open Access
Linzhou Zhang, Hao Lin, Jiajie Liang, et al.
International Journal of Oral Science (2025) Vol. 17, Iss. 1
Open Access
Efficacy and safety of PD-1 and PD-L1 inhibitors in advanced colorectal cancer: a meta-analysis of randomized controlled trials
Zhen-Zi Wang, Yuan Liu, Kedi Wang, et al.
BMC Gastroenterology (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Zhen-Zi Wang, Yuan Liu, Kedi Wang, et al.
BMC Gastroenterology (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Imaging and monitoring of granzyme B in the immune response
Xiangxia Li, Guiyuan Chen, Kecheng Wu, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2023) Vol. 16, Iss. 1
Closed Access | Times Cited: 3
Xiangxia Li, Guiyuan Chen, Kecheng Wu, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2023) Vol. 16, Iss. 1
Closed Access | Times Cited: 3
Significance of Multi-Cancer Genome Profiling Testing for Breast Cancer: A Retrospective Analysis of 3326 Cases from Japan’s National Database
Kyoka Kawabata, Hinano Nishikubo, Saki Kanei, et al.
Genes (2024) Vol. 15, Iss. 6, pp. 792-792
Open Access
Kyoka Kawabata, Hinano Nishikubo, Saki Kanei, et al.
Genes (2024) Vol. 15, Iss. 6, pp. 792-792
Open Access
PD-L1 expression in testicular germ cell tumors undergoing spontaneous regression
Ivan Novák, Miroslav Tomić, Denis Mulabdić, et al.
Biomolecules and Biomedicine (2024) Vol. 24, Iss. 6, pp. 1751-1760
Open Access
Ivan Novák, Miroslav Tomić, Denis Mulabdić, et al.
Biomolecules and Biomedicine (2024) Vol. 24, Iss. 6, pp. 1751-1760
Open Access
Programmed death receptor-1/programmed death-ligand 1 inhibitors: Clinical progress and biomarker exploration in gastric cancer
Jin Shi, Xudong Song, Zihao Gao, et al.
Heliyon (2024) Vol. 10, Iss. 20, pp. e38710-e38710
Open Access
Jin Shi, Xudong Song, Zihao Gao, et al.
Heliyon (2024) Vol. 10, Iss. 20, pp. e38710-e38710
Open Access
Mutation burden and anti-PD-1 outcomes are not universally associated with immune cell infiltration or lymphoid activation
David Hsiehchen, Andrew Elliott, Joanne Xiu, et al.
Cancer Cell (2024)
Closed Access
David Hsiehchen, Andrew Elliott, Joanne Xiu, et al.
Cancer Cell (2024)
Closed Access
